These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22007842)

  • 61. ["Cognitive doping": meaning and stakes].
    De Pauw E
    J Int Bioethique; 2011; 22(3-4):79-92, 195-6. PubMed ID: 22238909
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Nootropes (cognition enhancers) and neuroprotectors].
    Vornin TA; Seredenin SB
    Eksp Klin Farmakol; 2007; 70(4):44-58. PubMed ID: 18078043
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hacking the Brain: Dimensions of Cognitive Enhancement.
    Dresler M; Sandberg A; Bublitz C; Ohla K; Trenado C; Mroczko-Wąsowicz A; Kühn S; Repantis D
    ACS Chem Neurosci; 2019 Mar; 10(3):1137-1148. PubMed ID: 30550256
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Can intelligence be increased with drugs?].
    Virsu V
    Duodecim; 2000; 116(15):1525-6. PubMed ID: 12001471
    [No Abstract]   [Full Text] [Related]  

  • 65. Enhancement, ethics and society: towards an empirical research agenda for the medical humanities and social sciences.
    Pickersgill M; Hogle L
    Med Humanit; 2015 Dec; 41(2):136-42. PubMed ID: 26260624
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acute cognitive effects of donepezil in young, healthy volunteers.
    Zaninotto AL; Bueno OF; Pradella-Hallinan M; Tufik S; Rusted J; Stough C; Pompéia S
    Hum Psychopharmacol; 2009 Aug; 24(6):453-64. PubMed ID: 19637397
    [TBL] [Abstract][Full Text] [Related]  

  • 67. American culture and neuro-cognitive enhancing drugs.
    Flaskerud JH
    Issues Ment Health Nurs; 2010 Jan; 31(1):62-3. PubMed ID: 19951164
    [No Abstract]   [Full Text] [Related]  

  • 68. Opinions, attitudes and practices of Australian neurologists with regard to epilepsy and driving.
    Beran RG; Ainley LA; Beran ME
    Intern Med J; 2007 Apr; 37(4):251-7. PubMed ID: 17388866
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Putative cognitive enhancers in preclinical models related to schizophrenia: the search for an elusive target.
    Barak S; Weiner I
    Pharmacol Biochem Behav; 2011 Aug; 99(2):164-89. PubMed ID: 21420999
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neurologists for patient safety: where we stand, time to deliver.
    Glick TH; Rizzo M; Stern BJ; Feinberg DM
    Neurology; 2006 Dec; 67(12):2119-23. PubMed ID: 17190931
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Considering the causes and implications of ambivalence in using medicine for enhancement.
    Forlini C; Racine E
    Am J Bioeth; 2011 Jan; 11(1):15-7. PubMed ID: 21240798
    [No Abstract]   [Full Text] [Related]  

  • 72. Expectations regarding cognitive enhancement create substantial challenges.
    Racine E; Forlini C
    J Med Ethics; 2009 Aug; 35(8):469-70. PubMed ID: 19644002
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacological cognitive enhancement in healthy people: potential and concerns.
    Hyman S; Volkow N; Nutt D
    Neuropharmacology; 2013 Jan; 64():8-12. PubMed ID: 23145451
    [No Abstract]   [Full Text] [Related]  

  • 74. The brain as an agentic system: how the brain is articulated in the field of neuroenhancement.
    Brenninkmeijer J
    Sociol Health Illn; 2019 Jan; 41(1):112-127. PubMed ID: 30155996
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Neuroenhancement].
    Gründer G; Bartsch T
    Nervenarzt; 2014 Dec; 85(12):1536-43. PubMed ID: 25403289
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Cognition on demand?--The wish for cognition-enhancing drugs in medicine].
    Synofzik M
    Ethik Med; 2006 Mar; 18(1):37-50. PubMed ID: 17153250
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The ethics of neuroenhancement.
    Chatterjee A
    Handb Clin Neurol; 2013; 118():323-34. PubMed ID: 24182389
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ethical aspects of the abuse of pharmaceutical enhancements by healthy people in the context of improving cognitive functions.
    Tomažič T; Čelofiga AK
    Philos Ethics Humanit Med; 2019 Apr; 14(1):7. PubMed ID: 31023334
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Humility pills: building an ethics of cognitive enhancement.
    Goodman R
    J Med Philos; 2014 Jun; 39(3):258-78. PubMed ID: 24847120
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmaceutical enhancement and medical professionals.
    Enck GG
    Med Health Care Philos; 2014 Feb; 17(1):23-8. PubMed ID: 23922180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.